Insights

Innovative Drug Discovery Tech Pharmacelera specializes in advanced computational drug discovery solutions utilizing Quantum Mechanics and Machine Learning, enabling pharmaceutical companies to identify novel compounds more efficiently and creatively. This positions the company as a valuable partner for organizations seeking to enhance their early-stage drug research processes.

Target Market Focus With expertise spanning target identification to lead optimization, Pharmacelera serves biotech and pharma firms aiming to de-risk their drug development projects through sophisticated computational tools, offering potential avenues for collaborations and licensing agreements.

Emerging Market Presence Operating in Barcelona with a small but growing team, Pharmacelera presents an opportunity for clients to engage with innovative European biotech startups that are leveraging high-performance computing and AI to transform drug discovery.

Funding and Growth Potential Although revenue remains modest (up to 1 million USD), the company has secured significant funding of 1.7 million USD, indicating scope for scaling and partnership opportunities as it expands its technological solutions and client base.

Technological Edge By integrating Quantum Mechanics, Machine Learning, and HPC, Pharmacelera offers cutting-edge computational chemistry services, appealing to companies looking to incorporate advanced AI-driven solutions into their drug R&D pipelines for competitive advantage.

Similar companies to Pharmacelera

Pharmacelera Tech Stack

Pharmacelera uses 8 technology products and services including WordPress, Zoho Mail, JSON-LD, and more. Explore Pharmacelera's tech stack below.

  • WordPress
    Content Management System
  • Zoho Mail
    Email
  • JSON-LD
    Javascript Frameworks
  • Element UI
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Google Maps
    Maps
  • SWFObject
    Miscellaneous
  • Essential Addons for Elementor
    Web Platform Extensions

Media & News

Pharmacelera's Email Address Formats

Pharmacelera uses at least 1 format(s):
Pharmacelera Email FormatsExamplePercentage
First.Last@pharmacelera.comJohn.Doe@pharmacelera.com
41%
First.Middle@pharmacelera.comJohn.Michael@pharmacelera.com
9%
First.Last@pharmacelera.comJohn.Doe@pharmacelera.com
41%
First.Middle@pharmacelera.comJohn.Michael@pharmacelera.com
9%

Frequently Asked Questions

What is Pharmacelera's official website and social media links?

Minus sign iconPlus sign icon
Pharmacelera's official website is pharmacelera.com and has social profiles on LinkedInCrunchbase.

What is Pharmacelera's SIC code NAICS code?

Minus sign iconPlus sign icon
Pharmacelera's SIC code is 7372 - Prepackaged Software NAICS code is 5112 - Software Publishers.

How many employees does Pharmacelera have currently?

Minus sign iconPlus sign icon
As of December 2025, Pharmacelera has approximately 23 employees across 2 continents, including EuropeNorth America. Key team members include Cto And Co Founder: E. H.Cfo: G. C.Chief Business Development Officer: R. H.. Explore Pharmacelera's employee directory with LeadIQ.

What industry does Pharmacelera belong to?

Minus sign iconPlus sign icon
Pharmacelera operates in the Software Development industry.

What technology does Pharmacelera use?

Minus sign iconPlus sign icon
Pharmacelera's tech stack includes WordPressZoho MailJSON-LDElement UIjQuery MigrateGoogle MapsSWFObjectEssential Addons for Elementor.

What is Pharmacelera's email format?

Minus sign iconPlus sign icon
Pharmacelera's email format typically follows the pattern of First.Last@pharmacelera.com. Find more Pharmacelera email formats with LeadIQ.

How much funding has Pharmacelera raised to date?

Minus sign iconPlus sign icon
As of December 2025, Pharmacelera has raised $1.7M in funding. The last funding round occurred on Apr 01, 2023 for $1.7M.

When was Pharmacelera founded?

Minus sign iconPlus sign icon
Pharmacelera was founded in 2015.

Pharmacelera

Software DevelopmentCatalonia, Spain11-50 Employees

Quantum-Mechanics and Machine Learning Drug Discovery.

Pharmacelera develops proprietary Computer-Aided Drug Design software and provides access to its technology through flexible licensing options and computational chemistry services. The methodology mines an unexploited chemical space, finding starting points with larger chemical diversity and improving the creativity of chemists.

The technology is based on accurate Quantum-Mechanics algorithms, Machine Learning and High-Performance Computing (HPC) and it derives from more than 25 years of research.

Pharmacelera helps companies in Target Identification, Hit-Identification, Hit-to-Lead and Lead Optimization drug discovery stages by finding novel hits, improving ligand binding properties (ADME, Tox, ...), obtaining insights of ligand / receptor interactions and identifying original backup compounds.

Learn more on how to de-risk your drug discovery project by emailing us at contact@pharmacelera.com or by visiting our webpage at www.pharmacelera.com

Section iconCompany Overview

SIC Code
7372 - Prepackaged Software
NAICS Code
5112 - Software Publishers
Founded
2015
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1.7M

    Pharmacelera has raised a total of $1.7M of funding over 4 rounds. Their latest funding round was raised on Apr 01, 2023 in the amount of $1.7M.

  • $1M

    Pharmacelera's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1.7M

    Pharmacelera has raised a total of $1.7M of funding over 4 rounds. Their latest funding round was raised on Apr 01, 2023 in the amount of $1.7M.

  • $1M

    Pharmacelera's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.